Also, further research is needed to identify surrogate blood biomarkers as a potential screening tool for PAH, which may reduce the time to diagnosis. 21 Additionally, pulmonary function testing ...

With pulmonary hypertension, the heart has to work harder to carry blood from the heart to the lungs, and symptoms such as ...

The Munhall resident’s trouble breathing led to a diagnosis of pulmonary hypertension, high blood pressure in the blood vessels in the lungs. Pulmonary hypertension is a rare, incurable lung ...

The top articles about pulmonary arterial hypertension (PAH) in 2024 included FDA approvals, the effect of salt substitutes ...

After the FDA approved both combination macitentan/tadalafil (Opsynvi) and the biologic therapy sotatercept (Winrevair) for ...

PAH is a rare condition in children, but is often fatal if left untreated, and protocols for pediatric patients have not been ...

While high blood pressure can contribute to renovascular disease, having renal (kidney) problems can also increase blood ...

In the era of DOACs, risk for CTEPH following pulmonary embolism is affected by multiple factors, including gender and heart ...

Diagnosis of scimitar syndrome in neonates ... to determine which of these many factors are responsible for the pulmonary hypertension in an individual patient, so each factor should be considered ...

Steve Van Wormer has published nearly 500 podcasts about pulmonary hypertension (PH) — more than perhaps anyone working in rare diseases.

Cereno's expanded access program for investigational therapy CS1 covers 10 PAH patients, following a Phase 2a clinical trial.